Today, the EVP of Chemed Corporation (CHE), Spencer Lee, sold shares of CHE for $853.5K.
Following Spencer Lee’s last CHE Sell transaction on November 30, 2018, the stock climbed by 104.6%. In addition to Spencer Lee, 2 other CHE executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Chemed Corporation’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $474 million and quarterly net profit of $50.73 million. In comparison, last year the company earned revenue of $442 million and had a net profit of $54.97 million. CHE’s market cap is $6.71B and the company has a P/E ratio of 34.80. Currently, Chemed Corporation has an average volume of 101.2K.
One of the top 25 analysts, according to TipRanks.com, recently recommended Buy CHE with a $440 price target.
In the last 30 days, insiders have sold $960.3K worth of CHE shares and purchased $206.4K worth of CHE shares. The insider sentiment on Chemed Corporation has been neutral according to 43 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.
Spencer Lee’s trades have generated a -25.8% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
